Global Urological Cancer Drugs Market Research Report 2015-2025
- HEY3844684
- 116 Pages
- May 2020
- Healthcare
The global Urological Cancer Drugs market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Xofigo (Radium Ra 223 Dichloride)
Jevtana (Cabazitaxel)
Inlyta (Axitinib)
Votrient (Pazopanib Hydrochloride)
Sutent (Sunitinib Malate)
Zytiga (Abiraterone Acetate)
Xtandi (Enzalutamide)
Opdivo (Nivolumab)
Provenge (Sipuleucel-T)
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Novartis
Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Bristol-Myers Squibb
Abbott Laboratories
Celgene Corporation
Dendreon Corporation
Ferring Pharmaceuticals
GlaxoSmithKline
Indevus Pharmaceuticals Inc
Ipsen
Roche Healthcare
Sanofi S.A.
Tolmar Inc
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular Cancer
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Urological Cancer Drugs Picture
1.1.2 Specifications
Table Product Specifications of Urological Cancer Drugs
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Urological Cancer Drugs
Table Global Urological Cancer Drugs Market by Type, 2011-2022 (USD Million)
1.2.1.1 Xofigo (Radium Ra 223 Dichloride)
Table Xofigo (Radium Ra 223 Dichloride) Overview
1.2.1.2 Jevtana (Cabazitaxel)
Table Jevtana (Cabazitaxel) Overview
1.2.1.3 Inlyta (Axitinib)
Table Inlyta (Axitinib) Overview
1.2.1.4 Votrient (Pazopanib Hydrochloride)
Table Votrient (Pazopanib Hydrochloride) Overview
1.2.1.5 Sutent (Sunitinib Malate)
Table Sutent (Sunitinib Malate) Overview
1.2.1.6 Zytiga (Abiraterone Acetate)
Table Zytiga (Abiraterone Acetate) Overview
1.2.1.7 Xtandi (Enzalutamide)
Table Xtandi (Enzalutamide) Overview
1.2.1.8 Opdivo (Nivolumab)
Table Opdivo (Nivolumab) Overview
1.2.1.9 Provenge (Sipuleucel-T)
Table Provenge (Sipuleucel-T) Overview
1.2.2 by Application
Table Application Segment of Urological Cancer Drugs
Table Global Urological Cancer Drugs Market by Application, 2011-2022 (USD Million)
1.2.2.1 Prostate Cancer
Table Prostate Cancer Overview
1.2.2.2 Bladder Cancer
Table Bladder Cancer Overview
1.2.2.3 Kidney Cancer
Table Kidney Cancer Overview
1.2.2.4 Testicular Cancer
Table Testicular Cancer Overview
1.2.3 by Regions
Table Global Urological Cancer Drugs Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Urological Cancer Drugs
2.2 Upstream
Table Cost of Urological Cancer Drugs
Figure Manufacturing Process of Urological Cancer Drugs
2.3 Market
2.3.1 SWOT
Figure SWOT of Urological Cancer Drugs
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Urological Cancer Drugs
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Urological Cancer Drugs
3.4 Market Entry
Table Market Entry of Urological Cancer Drugs
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Xofigo (Radium Ra 223 Dichloride) Market, 2013-2018
Figure Xofigo (Radium Ra 223 Dichloride) Market Size and Growth, 2015-2019 (USD Million)
Figure Xofigo (Radium Ra 223 Dichloride) Market Size and Growth, 2015-2019 (in Volume)
Table Xofigo (Radium Ra 223 Dichloride) CAGR by Revenue and Volume, 2015-2019
4.1.2 Jevtana (Cabazitaxel) Market, 2013-2018
Figure Jevtana (Cabazitaxel) Market Size and Growth, 2015-2019 (USD Million)
Figure Jevtana (Cabazitaxel) Market Size and Growth, 2015-2019 (in Volume)
Table Jevtana (Cabazitaxel) CAGR by Revenue and Volume, 2015-2019
4.1.3 Inlyta (Axitinib) Market, 2013-2018
Figure Inlyta (Axitinib) Market Size and Growth, 2015-2019 (USD Million)
Figure Inlyta (Axitinib) Market Size and Growth, 2015-2019 (in Volume)
Table Inlyta (Axitinib) CAGR by Revenue and Volume, 2015-2019
4.1.4 Votrient (Pazopanib Hydrochloride) Market, 2013-2018
Figure Votrient (Pazopanib Hydrochloride) Market Size and Growth, 2015-2019 (USD Million)
Figure Votrient (Pazopanib Hydrochloride) Market Size and Growth, 2015-2019 (in Volume)
Table Votrient (Pazopanib Hydrochloride) CAGR by Revenue and Volume, 2015-2019
4.1.5 Sutent (Sunitinib Malate) Market, 2013-2018
Figure Sutent (Sunitinib Malate) Market Size and Growth, 2015-2019 (USD Million)
Figure Sutent (Sunitinib Malate) Market Size and Growth, 2015-2019 (in Volume)
Table Sutent (Sunitinib Malate) CAGR by Revenue and Volume, 2015-2019
4.1.6 Zytiga (Abiraterone Acetate) Market, 2013-2018
Figure Zytiga (Abiraterone Acetate) Market Size and Growth, 2015-2019 (USD Million)
Figure Zytiga (Abiraterone Acetate) Market Size and Growth, 2015-2019 (in Volume)
Table Zytiga (Abiraterone Acetate) CAGR by Revenue and Volume, 2015-2019
4.1.7 Xtandi (Enzalutamide) Market, 2013-2018
Figure Xtandi (Enzalutamide) Market Size and Growth, 2015-2019 (USD Million)
Figure Xtandi (Enzalutamide) Market Size and Growth, 2015-2019 (in Volume)
Table Xtandi (Enzalutamide) CAGR by Revenue and Volume, 2015-2019
4.1.8 Opdivo (Nivolumab) Market, 2013-2018
Figure Opdivo (Nivolumab) Market Size and Growth, 2015-2019 (USD Million)
Figure Opdivo (Nivolumab) Market Size and Growth, 2015-2019 (in Volume)
Table Opdivo (Nivolumab) CAGR by Revenue and Volume, 2015-2019
4.1.9 Provenge (Sipuleucel-T) Market, 2013-2018
Figure Provenge (Sipuleucel-T) Market Size and Growth, 2015-2019 (USD Million)
Figure Provenge (Sipuleucel-T) Market Size and Growth, 2015-2019 (in Volume)
Table Provenge (Sipuleucel-T) CAGR by Revenue and Volume, 2015-2019
4.2 Market Forecast
4.2.1 Xofigo (Radium Ra 223 Dichloride) Market Forecast, 2020-2025
Figure Xofigo (Radium Ra 223 Dichloride) Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Xofigo (Radium Ra 223 Dichloride) Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Xofigo (Radium Ra 223 Dichloride) CAGR by Revenue and Volume, 2012-2024
4.2.2 Jevtana (Cabazitaxel) Market Forecast, 2020-2025
Figure Jevtana (Cabazitaxel) Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Jevtana (Cabazitaxel) Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Jevtana (Cabazitaxel) CAGR by Revenue and Volume, 2012-2024
4.2.3 Inlyta (Axitinib) Market Forecast, 2020-2025
Figure Inlyta (Axitinib) Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Inlyta (Axitinib) Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Inlyta (Axitinib) CAGR by Revenue and Volume, 2012-2024
4.2.4 Votrient (Pazopanib Hydrochloride) Market Forecast, 2020-2025
Figure Votrient (Pazopanib Hydrochloride) Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Votrient (Pazopanib Hydrochloride) Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Votrient (Pazopanib Hydrochloride) CAGR by Revenue and Volume, 2012-2024
4.2.5 Sutent (Sunitinib Malate) Market Forecast, 2020-2025
Figure Sutent (Sunitinib Malate) Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Sutent (Sunitinib Malate) Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Sutent (Sunitinib Malate) CAGR by Revenue and Volume, 2012-2024
4.2.6 Zytiga (Abiraterone Acetate) Market Forecast, 2020-2025
Figure Zytiga (Abiraterone Acetate) Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Zytiga (Abiraterone Acetate) Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Zytiga (Abiraterone Acetate) CAGR by Revenue and Volume, 2012-2024
4.2.7 Xtandi (Enzalutamide) Market Forecast, 2020-2025
Figure Xtandi (Enzalutamide) Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Xtandi (Enzalutamide) Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Xtandi (Enzalutamide) CAGR by Revenue and Volume, 2012-2024
4.2.8 Opdivo (Nivolumab) Market Forecast, 2020-2025
Figure Opdivo (Nivolumab) Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Opdivo (Nivolumab) Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Opdivo (Nivolumab) CAGR by Revenue and Volume, 2012-2024
4.2.9 Provenge (Sipuleucel-T) Market Forecast, 2020-2025
Figure Provenge (Sipuleucel-T) Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Provenge (Sipuleucel-T) Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Provenge (Sipuleucel-T) CAGR by Revenue and Volume, 2012-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Prostate Cancer Market, 2013-2018
Figure Prostate Cancer Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Prostate Cancer CAGR by Revenue and Volume, 2015-2019
5.1.2 Bladder Cancer Market, 2013-2018
Figure Bladder Cancer Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Bladder Cancer CAGR by Revenue and Volume, 2015-2019
5.1.3 Kidney Cancer Market, 2013-2018
Figure Kidney Cancer Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Kidney Cancer CAGR by Revenue and Volume, 2015-2019
5.1.4 Testicular Cancer Market, 2013-2018
Figure Testicular Cancer Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Testicular Cancer CAGR by Revenue and Volume, 2015-2019
5.2 Market Forecast
5.2.1 Prostate Cancer Market Forecast, 2020-2025
Figure Prostate Cancer Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Prostate Cancer Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Prostate Cancer CAGR by Revenue and Volume, 2020-2025
5.2.2 Bladder Cancer Market Forecast, 2020-2025
Figure Bladder Cancer Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Bladder Cancer Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Bladder Cancer CAGR by Revenue and Volume, 2020-2025
5.2.3 Kidney Cancer Market Forecast, 2020-2025
Figure Kidney Cancer Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Kidney Cancer Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Kidney Cancer CAGR by Revenue and Volume, 2020-2025
5.2.4 Testicular Cancer Market Forecast, 2020-2025
Figure Testicular Cancer Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Testicular Cancer Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Testicular Cancer CAGR by Revenue and Volume, 2020-2025
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2015-2019
Figure Asia-Pacific Market Size and Growth, 2015-2019 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2015-2019 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2015-2019
Figure North America Market Size and Growth, 2015-2019 (USD Million)
Figure North America Market Size and Growth, 2015-2019 (in Volume)
Table North America CAGR by Revenue and Volume, 2015-2019
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2015-2019
Figure Europe Market Size and Growth, 2015-2019 (USD Million)
Figure Europe Market Size and Growth, 2015-2019 (in Volume)
Table Europe CAGR by Revenue and Volume, 2015-2019
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2015-2019
Figure South America Market Size and Growth, 2015-2019 (USD Million)
Figure South America Market Size and Growth, 2015-2019 (in Volume)
Table South America CAGR by Revenue and Volume, 2015-2019
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2015-2019
Figure Middle East & Africa Market Size and Growth, 2015-2019 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2015-2019 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2020-2025
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
6.2.2 North America Market Forecast, 2020-2025
Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table North America CAGR by Revenue and Volume, 2020-2025
6.2.3 Europe Market Forecast, 2020-2025
Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Europe CAGR by Revenue and Volume, 2020-2025
6.2.4 South America Market Forecast, 2020-2025
Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table South America CAGR by Revenue and Volume, 2020-2025
6.2.5 Middle East & Africa Market Forecast, 2020-2025
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
7 Market Competitive
7.1 Global Market by Vendors
Table Global Urological Cancer Drugs Market by Vendors, 2015-2019 (in Volume)
Table Global Urological Cancer Drugs Market Share by Vendors, 2015-2019 (USD Million)
Table Global Urological Cancer Drugs Market Share by Vendors, 2015-2019 (in Volume)
7.2 Market Concentration
Figure Urological Cancer Drugs Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Novartis
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Pfizer
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Johnson & Johnson
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 AstraZeneca
Table AstraZeneca Profile List
Table Microecological Modulator Operating Data of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Astellas
Table Astellas Profile List
Table Microecological Modulator Operating Data of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Bristol-Myers Squibb
Table Bristol-Myers Squibb Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Abbott Laboratories
Table Abbott Laboratories Profile List
Table Microecological Modulator Operating Data of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Celgene Corporation
Table Celgene Corporation Profile List
Table Microecological Modulator Operating Data of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 Dendreon Corporation
Table Dendreon Corporation Profile List
Table Microecological Modulator Operating Data of Dendreon Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 Ferring Pharmaceuticals
Table Ferring Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Ferring Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.11 GlaxoSmithKline
Table GlaxoSmithKline Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.12 Indevus Pharmaceuticals Inc
Table Indevus Pharmaceuticals Inc Profile List
Table Microecological Modulator Operating Data of Indevus Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.13 Ipsen
Table Ipsen Profile List
Table Microecological Modulator Operating Data of Ipsen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.14 Roche Healthcare
Table Roche Healthcare Profile List
Table Microecological Modulator Operating Data of Roche Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.15 Sanofi S.A.
Table Sanofi S.A. Profile List
Table Microecological Modulator Operating Data of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.16 Tolmar Inc
Table Tolmar Inc Profile List
Table Microecological Modulator Operating Data of Tolmar Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Table Product Specifications of Urological Cancer Drugs
Table Products Segment of Urological Cancer Drugs
Table Global Urological Cancer Drugs Market by Type, 2011-2022 (USD Million)
Table Xofigo (Radium Ra 223 Dichloride) Overview
Table Jevtana (Cabazitaxel) Overview
Table Inlyta (Axitinib) Overview
Table Votrient (Pazopanib Hydrochloride) Overview
Table Sutent (Sunitinib Malate) Overview
Table Zytiga (Abiraterone Acetate) Overview
Table Xtandi (Enzalutamide) Overview
Table Opdivo (Nivolumab) Overview
Table Provenge (Sipuleucel-T) Overview
Table Application Segment of Urological Cancer Drugs
Table Global Urological Cancer Drugs Market by Application, 2011-2022 (USD Million)
Table Prostate Cancer Overview
Table Bladder Cancer Overview
Table Kidney Cancer Overview
Table Testicular Cancer Overview
Table Global Urological Cancer Drugs Market by Region, 2011-2022 (USD Million)
Table Cost of Urological Cancer Drugs
Table Market Dynamics
Table Policy of Urological Cancer Drugs
Table GDP of Major Countries
Table Technology of Urological Cancer Drugs
Table Market Entry of Urological Cancer Drugs
Table Xofigo (Radium Ra 223 Dichloride) CAGR by Revenue and Volume, 2015-2019
Table Jevtana (Cabazitaxel) CAGR by Revenue and Volume, 2015-2019
Table Inlyta (Axitinib) CAGR by Revenue and Volume, 2015-2019
Table Votrient (Pazopanib Hydrochloride) CAGR by Revenue and Volume, 2015-2019
Table Sutent (Sunitinib Malate) CAGR by Revenue and Volume, 2015-2019
Table Zytiga (Abiraterone Acetate) CAGR by Revenue and Volume, 2015-2019
Table Xtandi (Enzalutamide) CAGR by Revenue and Volume, 2015-2019
Table Opdivo (Nivolumab) CAGR by Revenue and Volume, 2015-2019
Table Provenge (Sipuleucel-T) CAGR by Revenue and Volume, 2015-2019
Table Xofigo (Radium Ra 223 Dichloride) CAGR by Revenue and Volume, 2012-2024
Table Jevtana (Cabazitaxel) CAGR by Revenue and Volume, 2012-2024
Table Inlyta (Axitinib) CAGR by Revenue and Volume, 2012-2024
Table Votrient (Pazopanib Hydrochloride) CAGR by Revenue and Volume, 2012-2024
Table Sutent (Sunitinib Malate) CAGR by Revenue and Volume, 2012-2024
Table Zytiga (Abiraterone Acetate) CAGR by Revenue and Volume, 2012-2024
Table Xtandi (Enzalutamide) CAGR by Revenue and Volume, 2012-2024
Table Opdivo (Nivolumab) CAGR by Revenue and Volume, 2012-2024
Table Provenge (Sipuleucel-T) CAGR by Revenue and Volume, 2012-2024
Table Prostate Cancer CAGR by Revenue and Volume, 2015-2019
Table Bladder Cancer CAGR by Revenue and Volume, 2015-2019
Table Kidney Cancer CAGR by Revenue and Volume, 2015-2019
Table Testicular Cancer CAGR by Revenue and Volume, 2015-2019
Table Prostate Cancer CAGR by Revenue and Volume, 2020-2025
Table Bladder Cancer CAGR by Revenue and Volume, 2020-2025
Table Kidney Cancer CAGR by Revenue and Volume, 2020-2025
Table Testicular Cancer CAGR by Revenue and Volume, 2020-2025
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
Table North America CAGR by Revenue and Volume, 2015-2019
Table Europe CAGR by Revenue and Volume, 2015-2019
Table South America CAGR by Revenue and Volume, 2015-2019
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
Table North America CAGR by Revenue and Volume, 2020-2025
Table Europe CAGR by Revenue and Volume, 2020-2025
Table South America CAGR by Revenue and Volume, 2020-2025
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
Table Global Urological Cancer Drugs Market by Vendors, 2015-2019 (in Volume)
Table Global Urological Cancer Drugs Market Share by Vendors, 2015-2019 (USD Million)
Table Global Urological Cancer Drugs Market Share by Vendors, 2015-2019 (in Volume)
Table Price Factors List
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Profile List
Table Microecological Modulator Operating Data of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Profile List
Table Microecological Modulator Operating Data of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Laboratories Profile List
Table Microecological Modulator Operating Data of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Corporation Profile List
Table Microecological Modulator Operating Data of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dendreon Corporation Profile List
Table Microecological Modulator Operating Data of Dendreon Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ferring Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Ferring Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Indevus Pharmaceuticals Inc Profile List
Table Microecological Modulator Operating Data of Indevus Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ipsen Profile List
Table Microecological Modulator Operating Data of Ipsen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Healthcare Profile List
Table Microecological Modulator Operating Data of Roche Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi S.A. Profile List
Table Microecological Modulator Operating Data of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Tolmar Inc Profile List
Table Microecological Modulator Operating Data of Tolmar Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
